Professional Documents
Culture Documents
Same; Same; Actions; Judges; Judges are mere nominal parties.—There is no ROBERTO L. DEL ROSARIO, petitioner, vs. COURT OF APPEALS AND
dispute that petitioner has seasonably petitioned. On the other hand, it is JANITO CORPORATION, respondents.
elementary that the trial judge is a mere nominal party as clearly provided in
Actions; Injunction; Words and Phrases; Injunction, Defined; The controlling
Section 5, Rule 65 of the Revised Rules of Court where it shall be the duty of such
reason for the existence of the judicial power to issue the writ of injunction is that
person or persons interested in sustaining the proceedings in court, "to appear and
the court may thereby prevent a threatened or continuous irremediable injury to
defend, both in his or their own behalf and in behalf of the court or judge affected
some of the parties before their claims can be thoroughly investigated and
by the proceedings." Relative thereto "the judge whose order is under attack is
advisedly adjudicated.—Injunction is a preservative remedy for the protection of
merely a nominal party; wherefore, a judge in his official capacity should not be
substantive rights or interests. It is not a cause of action in itself but merely a
made to appear as a party seeking reversal of a decision that is unfavorable to the
provisional remedy, an adjunct to a main suit. The controlling reason for the
action taken by him." (Hon. Alcasid v. Samson, 102 Phil. 735-736; Tarona v.
existence of the judicial power to issue the writ is that the court may thereby
Sayo, 67 SCRA 508, 524; Lim Se v. Argel, 70 SCRA 378).
prevent a threatened or continuous irremediable injury to some of the parties
before their claims can be thoroughly investigated and advisedly adjudicated. It is
to be resorted to only when there is a pressing necessity to avoid injurious patented invention. In order to infringe a patent, a machine or device must perform
consequences which cannot be remedied under any standard of compensation. The the same function, or accomplish the same result by identical or substantially
application of the writ rests upon an alleged existence of an emergency or of a identical means and the principle or mode of operation must be substantially the
special reason for such an order before the case can be regularly heard, and the same. Del Rosario vs. Court of Appeals, 255 SCRA 152, G.R. No. 115106 March
essential conditions for granting such temporary injunctive relief are that the 15, 1996
complaint alleges facts which appear to be sufficient to constitute a cause of action
for injunction and that on the entire showing from both sides, it appears, in view
of all the circumstances, that the injunction is reasonably necessary to protect the
legal rights of plaintiff pending the litigation. SMITH KLINE BECKMAN CORPORATION, petitioner, vs. THE
HONORABLE COURT OF APPEALS and TRYCO PHARMA
Same; Same; There are only two requisites to be satisfied if an injunction is to CORPORATION, respondents.
issue, namely, the existence of the right to be protected, and that the facts against
which the injunction is to be directed are violative of said right.—A preliminary Intellectual Property Law; Appeals; Only questions of law may be raised in a
injunction may be granted at any time after the commencement of the action and petition for review on certiorari.—As has repeatedly been held, only questions of
before judgment when it is established that the defendant is doing, threatens, or is law may be raised in a petition for review on certiorari before this Court. Unless
about to do, or is procuring or suffering to be done, some acts probably in violation the factual findings of the appellate court are mistaken, absurd, speculative,
of the plaintiff’s rights. Thus, there are only two requisites to be satisfied if an conjectural, conflicting, tainted with grave abuse of discretion, or contrary to the
injunction is to issue, namely, the existence of the right to be protected, and that findings culled by the court of origin, this Court does not review them.
the facts against which the injunction is to be directed are violative of said right.
Same; Patents; When the language of its claims is clear and distinct, the patentee
Patent Law; Any new model of implements or tools of any industrial product even is bound thereby and may not claim anything beyond them.— When the language
if not possessed of the quality of invention but which is of practical utility is of its claims is clear and distinct, the patentee is bound thereby and may not claim
entitled to a patent for utility model.—The Patent Law expressly acknowledges anything beyond them. And so are the courts bound which may not add to or
that any new model of implements or tools of any industrial product even if not detract from the claims matters not expressed or necessarily implied, nor may they
possessed of the quality of invention but which is of practical utility is entitled to enlarge the patent beyond the scope of that which the inventor claimed and the
a patent for utility model. Here, there is no dispute that the letters patents issued patent office allowed, even if the patentee may have been entitled to something
to petitioner are for utility models of audio equipment. more than the words it had chosen would include.
Same; Evidence; Presumptions; Where a party introduces the patent in evidence, Same; Same; Infringement; Doctrine of Equivalents; Definition.—The doctrine of
if it is in due form, it affords a prima facie presumption of its correctness and equivalents provides that an infringement also takes place when a device
validity—the decision of the Director of Patents in granting the patent is always appropriates a prior invention by incorporating its innovative concept and,
presumed to be correct, and the burden then shifts to the other party to overcome although with some modification and change, performs substantially the same
this presumption by competent evidence.—In issuing, reissuing or withholding function in substantially the same way to achieve substantially the same result.
patents and extensions thereof, the Director of Patents determines whether the
Same; Same; Same; Same; The Doctrine of Equivalents thus requires satisfaction
patent is new and whether the machine or device is the proper subject of patent.
of the function-means-and-result test.—The doctrine of equivalents thus requires
In passing on an application, the Director decides not only questions of law but
satisfaction of the function-means-and-result test, the patentee having the burden
also questions of fact, i.e. whether there has been a prior public use or sale of the
to show that all three components of such equivalency test are met.
article sought to be patented. Where petitioner introduces the patent in evidence,
if it is in due form, it affords a prima facie presumption of its correctness and Damages; Actual Damages; Unearned Profits; It is necessary to prove the actual
validity. The decision of the Director of Patents in granting the patent is always amount of damages with a reasonable degree of certainty based on competent
presumed to be correct, and the burden then shifts to respondent to overcome this proof.—While indemnification for actual or compensatory damages covers not
presumption by competent evidence. only the loss suffered (damnum emergens) but also profits which the obligee failed
to obtain (lucrum cessans or ganacias frustradas), it is necessary to prove the actual
Same; Same; A utility model shall not be considered “new” if before the
amount of damages with a reasonable degree of certainty based on competent
application for a patent it has been publicly known or publicly used in this country
proof and on the best evidence obtainable by the injured party.
or has been described in a printed publication or publications circulated within the
country, or if it is substantially similar to any other utility model so known, used Same; Attorney’s Fees; Attorney’s fees cannot be awarded where there is no
or described within the country.—Under Sec. 55 of The Patent Law a utility model sufficient showing of bad faith.—Even if a claimant is compelled to litigate with
shall not be considered “new” if before the application for a patent it has been third persons or to incur expenses to protect its rights, still attorney’s fees may not
publicly known or publicly used in this country or has been described in a printed be awarded where no sufficient showing of bad faith could be reflected in a party’s
publication or publications circulated within the country, or if it is substantially persistence in a case other than an erroneous conviction of the righteousness of
similar to any other utility model so known, used or described within the country. his cause. Smith Kline Beckman Corporation vs. Court of Appeals, 409 SCRA 33,
Respondent corporation failed to present before the trial court competent evidence G.R. No. 126627 August 14, 2003
that the utility models covered by the Letters Patents issued to petitioner were not
new.
Same; Infringement; Words and Phrases; A patentee shall have the exclusive right PHIL PHARMAWEALTH, INC., petitioner, vs. PFIZER, INC. and PFIZER
to make, use and sell the patented machine, article or product for the purpose of (PHIL.) INC., respondents.
industry or commerce, throughout the territory of the Philippines for the term of
the patent, and such making, using or selling by any person without authorization Intellectual Property; Patents; The exclusive right of a patentee to make, use and
of the patentee constitutes infringement of his patent.—As may be gleaned herein, sell a patented product, article or process exists only during the term of the
the rights of petitioner as a patentee have been sufficiently established, contrary patent.—It is clear from the above-quoted provision of law that the exclusive right
to the findings and conclusions of respondent Court of Appeals. Consequently, of a patentee to make, use and sell a patented product, article or process exists
under Sec. 37 of The Patent Law, petitioner as a patentee shall have the exclusive only during the term of the patent. In the instant case, Philippine Letters Patent
right to make, use and sell the patented machine, article or product for the purpose No. 21116, which was the basis of respondents in filing their complaint with the
of industry or commerce, throughout the territory of the Philippines for the term BLA-IPO, was issued on July 16, 1987. This fact was admitted by respondents
of the patent, and such making, using or selling by any person without themselves in their complaint. They also admitted that the validity of the said
authorization of the patentee constitutes infringement of his patent. patent is until July 16, 2004, which is in conformity with Section 21 of RA 165,
providing that the term of a patent shall be seventeen (17) years from the date of
Same; Same; In order to infringe a patent, a machine or device must perform the issuance thereof. Section 4, Rule 129 of the Rules of Court provides that an
same function, or accomplish the same result by identical or substantially identical admission, verbal or written, made by a party in the course of the proceedings in
means and the principle or mode of operation must be substantially the same.—It the same case, does not require proof and that the admission may be contradicted
is elementary that a patent may be infringed where the essential or substantial only by showing that it was made through palpable mistake or that no such
features of the patented invention are taken or appropriated, or the device, machine admission was made.
or other subject matter alleged to infringe is substantially identical with the
Remedial Law; Injunction; Requisites to Warrant the Issuance of an Injunctive alleged perfected sale of real estate. On the other hand, the complaint in the
Relief.—From the foregoing, it can be inferred that two requisites must exist to Second Case seeks to declare such purported sale involving the same real property
warrant the issuance of an injunctive relief, namely: (1) the existence of a clear “as unenforceable as against the Bank,” which is the petitioner herein. In other
and unmistakable right that must be protected; and (2) an urgent and paramount words, in the Second Case, the majority stockholders, in representation of the
necessity for the writ to prevent serious damage. Bank, are seeking to accomplish what the Bank itself failed to do in the original
case in the trial court. In brief, the objective or the relief being sought, though
Same; Certiorari; Appeals; What is being questioned before the Court of Appeals worded differently, is the same, namely, to enable the petitioner Bank to escape
(CA) is a not a decision, but an interlocutory order of the Bureau of Legal Affairs from the obligation to sell the property to respondent.
of the Intellectual Property Office (BLA-IPO) denying respondents’ motion to
extend the life of the preliminary injunction issued in their favor.—It is true that Same; Same; Same; If the forum shopping is not considered willful and deliberate,
under Section 7(b) of RA 8293, otherwise known as the Intellectual Property Code the subsequent case shall be dismissed without prejudice, on the ground of either
of the Philippines, which is the presently prevailing law, the Director General of litis pendentia or res judicata; If the forum shopping is willful and deliberate, both
the IPO exercises exclusive appellate jurisdiction over all decisions rendered by (on all, if there are more than two) actions shall be dismissed with prejudice.—
the Director of the BLA-IPO. However, what is being questioned before the CA Juris-prudence holds that if the forum shopping is not considered willful and
is not a decision, but an interlocutory order of the BLA-IPO denying respondents’ deliberate, the subsequent case shall be dismissed without prejudice, on the
motion to extend the life of the preliminary injunction issued in their favor. ground of either litis pendentia or res judicata. However, if the forum shopping is
willful and deliberate, both (or all, if there are more than two) actions shall be
Same; Same; Same; Republic Act (RA) 8293 is silent with respect to any remedy dismissed with prejudice. In the present case, the Court finds that respondents did
available to litigants who intend to question an interlocutory order issued by the not deliberately violate the rule on non-forum shopping. Respondents may not be
Bureau of Legal Affairs of the Intellectual Property Office (BLA-IPO); totally blamed for erroneously believing that they can file separate actions simply
Respondents correctly resorted to the filing of a special civil action for certiorari on the basis of different patents. Moreover, in the suit filed with the RTC of Makati
with the Court of Appeals (CA) to question the assailed Orders of the Bureau of City, respondents were candid enough to inform the trial court of the pendency of
Legal Affairs of the Intellectual Property Office (BLA-IPO) as they cannot appeal the complaint filed with the BLA-IPO as well as the petition for certiorari filed
therefrom and they have no other plain, speedy and adequate remedy in the with the CA. On these bases, only Civil Case No. 04-754 should be dismissed on
ordinary course of law.—RA 8293 is silent with respect to any remedy available the ground of litis pendentia. Phil Pharmawealth, Inc. vs. Pfizer, Inc., 635 SCRA
to litigants who intend to question an interlocutory order issued by the BLA-IPO. 140, G.R. No. 167715 November 17, 2010
Moreover, Section 1(c), Rule 14 of the Rules and Regulations on Administrative
Complaints for Violation of Laws Involving Intellectual Property Rights simply
provides that interlocutory orders shall not be appealable. The said Rules and
Regulations do not prescribe a procedure within the administrative machinery to CRESER PRECISION SYSTEMS, INC., petitioner, vs. COURT OF
be followed in assailing orders issued by the BLA-IPO pending final resolution of APPEALS AND FLORO INTERNATIONAL CORP., respondents.
a case filed with them. Hence, in the absence of such a remedy, the provisions of
the Rules of Court shall apply in a suppletory manner, as provided under Section Patents; Infringement; Actions; Words and Phrases; Only the patentee or his
3, Rule 1 of the same Rules and Regulations. Hence, in the present case, successors-in-interest may file an action for infringement—the phrase “anyone
respondents correctly resorted to the filing of a special civil action for certiorari possessing any right, title or interest in and to the patented invention” in Sec. 42
with the CA to question the assailed Orders of the BLA-IPO, as they cannot appeal of R.A. 165 refers only to the patentee’s successors-in-interest, assignees or
therefrom and they have no other plain, speedy and adequate remedy in the grantees.—Section 42 of R.A. 165, otherwise known as the Patent Law, explicitly
ordinary course of law. This is consistent with Sections 1 and 4, Rule 65 of the provides: Section 42. Civil action for infringement.—Any patentee, or anyone
Rules of Court, as amended. possessing any right, title or interest in and to the patented invention, whose rights
have been infringed, may bring a civil action before the proper Court of First
Same; Courts; Doctrine of Primary Jurisdiction; It is settled that one of the Instance (now Regional Trial Court), to recover from the infringer damages
exceptions to the doctrine of primary jurisdiction is where the question involved sustained by reason of the infringement and to secure an injunction for the
is purely legal and will ultimately have to be decided by the courts of justice.— protection of his rights. x x x Under the aforequoted law, only the patentee or his
The propriety of extending the life of the writ of preliminary injunction issued by successors-in-interest may file an action for infringement. The phrase “anyone
the BLA-IPO in the exercise of its quasi-judicial power is no longer a matter that possessing any right, title or interest in and to the patented invention” upon which
falls within the jurisdiction of the said administrative agency, particularly that of petitioner maintains its present suit, refers only to the patentee’s successors-in-
its Director General. The resolution of this issue which was raised before the CA interest, assignees or grantees since actions for infringement of patent may be
does not demand the exercise by the IPO of sound administrative discretion brought in the name of the person or persons interested, whether as patentee,
requiring special knowledge, experience and services in determining technical and assignees, or as grantees, of the exclusive right.
intricate matters of fact. It is settled that one of the exceptions to the doctrine of
primary jurisdiction is where the question involved is purely legal and will Same; Same; Same; A person or entity who has not been granted letters patent
ultimately have to be decided by the courts of justice. This is the case with respect over an invention and has not acquired any right or title thereto either as assignee
to the issue raised in the petition filed with the CA. or as licensee, has no cause of action for infringement because the right to maintain
an infringement suit depends on the existence of the patent.—Moreover, there can
Same; Actions; Forum Shopping; Definition of Forum Shopping; Elements of be no infringement of a patent until a patent has been issued, since whatever right
Forum Shopping.—Forum shopping is defined as the act of a party against whom one has to the invention covered by the patent arises alone from the grant of patent.
an adverse judgment has been rendered in one forum, of seeking another (and In short, a person or entity who has not been granted letters patent over an
possibly favorable) opinion in another forum (other than by appeal or the special invention and has not acquired any right or title thereto either as assignee or as
civil action of certiorari), or the institution of two (2) or more actions or licensee, has no cause of action for infringement because the right to maintain an
proceedings grounded on the same cause on the supposition that one or the other infringement suit depends on the existence of the patent.
court would make a favorable disposition. The elements of forum shopping are:
(a) identity of parties, or at least such parties that represent the same interests in Same; Same; Same; A person claiming to be an inventor of an article has no right
both actions; (b) identity of rights asserted and reliefs prayed for, the reliefs being of property over the same upon which it can maintain a suit unless it obtains a
founded on the same facts; (c) identity of the two preceding particulars, such that patent therefor.—Petitioner admits it has no patent over its aerial fuze. Therefore,
any judgment rendered in the other action will, regardless of which party is it has no legal basis or cause of action to institute the petition for injunction and
successful, amount to res judicata in the action under consideration. damages arising from the alleged infringement by private respondent. While
petitioner claims to be the first inventor of the aerial fuze, still it has no right of
Same; Same; Same; It is settled by the Court in several cases that the filing by a property over the same upon which it can maintain a suit unless it obtains a patent
party of two apparently different actions but with the same objective constitutes therefor. Under American jurisprudence, an inventor has no common-law right to
forum shopping.—It is settled by this Court in several cases that the filing by a a monopoly of his invention. He has the right to make, use and vend his own
party of two apparently different actions but with the same objective constitutes invention, but if he voluntarily discloses it, such as by offering it for sale, the world
forum shopping. The Court discussed this species of forum shopping as follows: is free to copy and use it with impunity. A patent, however, gives the inventor the
Very simply stated, the original complaint in the court a quo which gave rise to right to exclude all others. As a patentee, he has the exclusive right of making,
the instant petition was filed by the buyer (herein private respondent and his using or selling the invention.
predecessors-in-interest) against the seller (herein petitioners) to enforce the
Same; Same; Same; Anyone who has no patent over an invention but claims to TECHNOLOGY TRANSFER and DOCTORS PHARMACEUTICALS,
have a right or interest thereto can not file an action for declaratory judgment or INC., respondents.
injunctive suit which is not recognized in this jurisdiction but he can, under
Section 28 of the Patent Law, file a petition for cancellation of the patent within Patents and Trademarks; Treaties and Conventions; Paris Convention for the
three (3) years from the publication of the patent with the Director of Patents.— Protection of Industrial Property (“Paris Convention”); Section A(2) of Article 5
Further, the remedy of declaratory judgment or injunctive suit on patent invalidity of the Paris Convention unequivocally and explicitly respects the right of member
relied upon by petitioner cannot be likened to the civil action for infringement countries to adopt legislative measures to provide for the grant of compulsory
under Section 42 of the Patent Law. The reason for this is that the said remedy is licenses to prevent abuses which might result from the exercise of the exclusive
available only to the patent holder or his successors-in-interest. Thus, anyone who rights conferred by the patent.—It is thus clear that Section A(2) of Article 5 above
has no patent over an invention but claims to have a right or interest thereto can unequivocally and explicitly respects the right of member countries to adopt
not file an action for declaratory judgment or injunctive suit which is not legislative measures to provide for the grant of compulsory licenses to prevent
recognized in this jurisdiction. Said person, however, is not left without any abuses which might result from the exercise of the exclusive rights conferred by
remedy. He can, under Section 28 of the aforementioned law, file a petition for the patent. An example provided of possible abuses is “failure to work;” however,
cancellation of the patent within three (3) years from the publication of said patent as such is merely supplied by way of an example, it is plain that the treaty does
with the Director of Patents and raise as ground therefor that the person to whom not preclude the inclusion of other forms or categories of abuses.
the patent was issued is not the true and actual inventor. Hence, petitioner’s
remedy is not to file an action for injunction or infringement but to file a petition Same; Same; Same; Statutes; Republic Act No. 165; Monopolies; Certainly, the
for cancellation of private respondent’s patent. Petitioner however failed to do so. growth of monopolies was among the abuses which Section 1, Article 5 of the
As such, it can not now assail or impugn the validity of the private respondent’s Paris Convention foresaw and which Congress likewise wished to prevent in
letters patent by claiming that it is the true and actual inventor of the aerial fuze. enacting R.A. No. 165.—Section 34 of R.A. No. 165, even if the Act was enacted
Creser Precision Systems, Inc. vs. Court of Appeals, 286 SCRA 13, G.R. No. prior to the Philippines’ adhesion to the Convention, fits well within the
118708 February 2, 1998 aforequoted provisions of Article 5 of the Paris Convention. In the explanatory
note of Bill No. 1156 which eventually became R.A. No. 165, the legislative intent
in the grant of a compulsory license was not only to afford others an opportunity
to provide the public with the quantity of the patented product, but also to prevent
BARRY JOHN PRICE, JOHN WATSON CLITHERON and JOHN the growth of monopolies. Certainly, the growth of monopolies was among the
BRADSHAW, Assignors to ALLEN & HANBURYS, LTD., petitioners, vs. abuses which Section A, Article 5 of the Convention foresaw, and which our
UNITED LABORATORIES, respondent. Congress likewise wished to prevent in enacting R.A. No. 165.
Commercial Law; Patents; Director of Patents authorized to fix the terms and Same; Same; General Agreement on Tariff and Trade; World Trade Organization;
conditions of the compulsory license.—The first assignment of error has no merit. The GATT Treaty, Uruguay Act (Uruguay Final Act) has no retroactive effect.—
The terms and conditions of the compulsory license were fixed by the Director of Neither may petitioner validly invoke what it designates as the GATT Treaty,
Patents after a hearing and careful consideration of the evidence of the parties and Uruguay Round. This act is better known as the Uruguay Final Act signed for the
in default of an agreement between them as to the terms of the “license. This he is Philippines on 15 April 1994 by Trade and Industry Secretary Rizalino Navarro.
authorized to do under Section 36 of Republic Act No. 165. Forming integral parts thereof are the Agreement Establishing the World Trade
Organization, the Ministerial Declarations and Decisions, and the Understanding
Same; Same; Factual finding that UNILAB has the capability to use the patented on Commitments in Financial Services. The Agreement establishing the World
compound in the manufacture of an anti-ulcer pharmaceutical preparation Trade Organization includes various agreements and associated legal instruments.
supported by substantial evidence.—The Director’s finding that UNILAB has the It was only on 14 December 1994 that the Philippine Senate, in the exercise of its
capability to use the patented compound in the manufacture of an anti-ulcer power under Section 21 of Article VII of the Constitution, adopted Senate
pharmaceutical preparation is a factual finding which is supported by substantial Resolution No. 97 concurring in the ratification by the President of the Agreement.
evidence, hence, the Court of Appeals did not commit a reversible error in The President signed the instrument of ratification on 16 December 1994. But
affirming it. Of indubitable relevance to this point is evidence that UNILAB has plainly, this treaty has no retroactive effect. Accordingly, since the challenged
been engaged in the business of manufacturing drugs and pharmaceutical products BPTTT decision was rendered on 14 February 1994, petitioner cannot avail of the
for the past thirty (30) years, that it is the leading drug manufacturer in the country, provisions of the GATT treaty.
that it has the necessary equipment and technological expertise for the
development of solid dosage forms or for tablet, capsule, and liquid preparations, Same; Evidence; Findings of facts of the Court of Appeals are conclusive;
and that it maintains standards and procedures to ensure the quality of its products. Exceptions.—The second and third assigned errors relate more to the factual
Even if it were true, as alleged by the patentee (although it is denied by UNILAB), findings of the Court of Appeals. Well-established is the principle that the findings
that its capability to use the patented compound was only acquired after the of facts of the latter are conclusive, unless: (1) the conclusion is a finding grounded
petition for compulsory licensing had been filed, the important thing is that such entirely on speculation or conjecture; (2) the inference made is manifestly absurd;
capability was proven to exist during the hearing of the petition. (3) there is grave abuse of discretion in the appreciation of facts; (4) the judgment
is premised on a misapprehension of facts; (5) the findings of fact are conflicting;
Same; Same; Same; No error in granting a compulsory license over the entire and (6) the Court of Appeals, in making its findings, went beyond the issues of
patented invention for there is no law requiring that the license be limited to a the case and the same is contrary to the admissions of both the appellant and
specific embodiment of the invention or, to a particular claim; Petitioner cannot appellee. Petitioner has not convinced us that the instant case falls under any of
complain of deprivation of property rights without just compensation.—The the exceptions. On the contrary, we find the findings of fact and conclusions of
patented invention in this case relates to medicine and is necessary for public respondent Court of Appeals and that of the BPTTT to be fully supported by the
health as it can be used as component in the manufacture of anti-ulcer medicine. evidence and the applicable law and jurisprudence on the matter.
The Director of Patents did not err in granting a compulsory license over the entire
patented invention for there is no law requiring that the license be limited to a Same; Due Process; There is no denial of due process where fullblown adversarial
specific embodiment of the invention, or, to a particular claim. The invention in proceedings are conducted before an administrative body.—Petitioner’s claim of
this case relates to new aminoalkyl derivatives which have histamine H2 blocking violations of the due process and eminent domain clauses of the Bill of Rights are
activity, having the general formula (I) and physiologically acceptable salts, N- mere conclusions which it failed to convincingly support. As to the due process
oxides and hydrates thereof. The compound ranitidine hydrochloride named in argument, suffice it to say that full-blown adversarial proceedings were conducted
Claim 45 is also covered by General Claim I and several other sub-generic claims. before the BPTTT pursuant to the Patent Law. We agree with the Court of Appeals
Therefore, a license for Claim 45 alone would not be fully comprehensive. In any that the BPTTT exhaustively studied the facts and its findings were fully
event, since the petitioner will be paid royalties on the sales of any products the supported by substantial evidence.
licensee may manufacture using any or all of the patented compounds, the
petitioner cannot complain of a deprivation of property rights without just Same; Same; A patent holder is not unduly deprived of its property rights where
compensation. Price vs. United Laboratories, 166 SCRA 133, No. L-82542 the law not only grants him a protective period of two years to enjoy his exclusive
September 29, 1988 rights thereto but subsequently recognizes just compensation in the form of
royalties.—It cannot likewise be claimed that petitioner was unduly deprived of
SMITH KLINE & FRENCH LABORATORIES, LTD., petitioner, vs. its property rights, as R.A. No. 165 not only grants the patent holder a protective
COURT OF APPEALS, BUREAU OF PATENTS, TRADEMARKS AND
period of two years to enjoy his exclusive rights thereto; but subsequently, the law
recognizes just compensation in the form of royalties.